Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Candida antigen refers to a mix of fungal cell wall components—primarily mannoproteins and mannans—derived from Candida species such as Candida albicans. These antigens are not a single molecule but complex heterogenous mixtures of glycoproteins, polysaccharides, and associated proteins, often used in diagnostic assays to detect candidiasis by measuring antigen or antibody levels in patient serum. The immunodominant antigen is generally mannan (a phosphomannoprotein complex), whose structure and antigenicity can vary by fungal strain, morphology, and environmental conditions. "Candida antigen" is not a specific molecular target but a functional group of components involved in immune recognition and clinical diagnostics rather than a druggable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Candida antigen.